NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Strip, Model No. 300900

FDA Device Recall #Z-1251-2022 — Class II — May 13, 2022

Recall Summary

Recall Number Z-1251-2022
Classification Class II — Moderate risk
Date Initiated May 13, 2022
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm NeuMoDx Molecular Inc
Location Ann Arbor, MI
Product Type Devices
Quantity 459 kits US; 1626 kits OUS

Product Description

NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Strip, Model No. 300900

Reason for Recall

There is a potential for reduced analytical sensitivity for samples in the 1x - 3x LOD range for Flu A, RSV, and SARS-CoV-2 targets. This may lead to false negative results, allowing ongoing transmission to others and delaying appropriate treatment.

Distribution Pattern

Domestic distribution to FL, NY, MD, PA, VA, MI, TN, NM. Foreign distribution to AT, AU, BE, CH, DE, FI, FR, GB, GR, HK, ID, IT, LT, NL, SA, SE, and SI.

Lot / Code Information

UDI-DI (GTIN): 10814278020830 Cartridge lot numbers 111915 - 117508

Other Recalls from NeuMoDx Molecular Inc

Recall # Classification Product Date
Z-2255-2023 Class II NeuMoDx Cartridge-used for extraction, purifica... May 24, 2023
Z-2093-2023 Class III NeuMoDx SARS-CoV-2 Assay -IVD intended for the... May 15, 2023
Z-1000-2022 Class II NeuMoDx Cartridge-For in vitro diagnostic use w... Feb 18, 2022
Z-0738-2022 Class II NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Str... Jan 21, 2022
Z-1978-2021 Class II NeuMoDx Cartridge, For In Vitro Diagnostic Use ... May 4, 2021

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.